Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Price:
461.195
USD
-3.49%
Market Closed
Market Cap:
$117B
Relative Value
The Relative Value of one
VRTX
stock under the Base Case scenario is
hidden
USD.
Compared to the current market price of 461.195 USD,
Vertex Pharmaceuticals Inc
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
VRTX Relative Value
HIDDEN
Multiples Across Competitors
VRTX Competitors Multiples
Vertex Pharmaceuticals Inc Competitors
Vertex Pharmaceuticals Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
116.8B USD | 9.8 | 29.6 | 22.3 | 23.3 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
409.4B USD | 6.7 | 97.8 | 16 | 22.2 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
197.3B USD | 5.4 | 25.6 | 14.7 | 14.7 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
179.1B USD | 6.1 | 21.1 | 13.2 | 16.2 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
81B USD | 5.6 | 18 | 13.4 | 15.3 | |
| AU |
|
CSL Ltd
ASX:CSL
|
70.3B AUD | 3.2 | 35.7 | 11.7 | 14.7 | |
| NL |
|
argenx SE
XBRU:ARGX
|
39.7B EUR | 10.9 | 35 | 38 | 38.7 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 | |
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
42.6B USD | 11.5 | 136.1 | 75.9 | 84.3 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
